AstraZeneca & Sanofi Win European Nod for RSV-Preventing Drug for Infants
Respiratory syncytial virus’s early surge this year has some healthcare officials concerned that this season could be a rough one....
dc
With PBM satisfaction on the decline, Centene switches to Express Scripts
Shortly after a new survey revealed that health plans’ satisfaction with pharmacy benefit managers (PBMs) is down, Centene announced this...
How to bring direct primary care into the home
Homebound patients often struggle with complex medical conditions among the costliest in healthcare. One recent analysis concluded that homebound people...
Here’s 40 years of cardiac advancements that few know about
Like much of healthcare, the roots of modern cardiology may be traced back to Hippocrates. Considered the father of medicine,...
Remote patient monitoring applications from cancer care to sleep
This article is part of a series sponsored by HLTH highlighting topics that will be discussed at the HLTH conference...
Sanofi exec jumps to Owkin to ramp up the AI biotech’s pharma partnership plans
As Sanofi’s top business partnering executive, Alban de La Sablière led the pharmaceutical giant’s collaboration talks with numerous companies,...
Improving the patient financial experience requires an end to ‘mafia’-style price negotiations
Though healthcare may be the single most important purchase most people will make in their lifetime, it’s also the one...
AHA: Legislative action needed to prevent MA plans from harming Medicare beneficiaries
Medicare Advantage plans use a series of policies that hurt Medicare beneficiaries, lead to physician burnout and bring up healthcare...
Penn spinout Capstan aims for next cell therapy frontier: in vivo cell engineering
University of Pennsylvania scientists who pioneered advances in cell therapy and messenger RNA have unveiled a new venture aiming...
Arpeggio Biosciences rakes in $17M to measure the transcriptome
How can drug developers design therapies around cellular networks rather than a single target? That is the question Arpeggio Biosciences...
